The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Characterizing viral vector products and associated impurities is critical to ensuring the safety and efficacy of viral vector therapies. View the following infographic for tips and aspects to consider for robust viral vector analytical characterization, including strategies to overcome challenges in assessing impurities and defining critical quality attributes (CQAs).